Effect of Saugandhik taila in Fungal Infection

Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Saugandhik Taila in Dadru Kustha With Special Reference To Tinea Infection - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102693

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 70 years Sex All Genders Patients with signs and symptoms of Dadru kushta (Tinea infection) like Kandu (itching) Raga (Redness) Pidaka (skin eruption) and Udgat mandal (raised Patch) Patients understanding and willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patient having skin lesion other than Dadru kushtha (Tinea Infection) Like Eczema Psoriasis Urticaria Patients with serious illness like HIV Malignancy Hepatitis B SLE

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of saugandhik tail in dadru KushtaTimepoint: 15th and 30th day	—

Secondary

Measure	Time frame
To Evaluate adverse effects of saugandhik tail if anyTimepoint: 15th and 30th day	—

Countries

India

Contacts

Public ContactDr Shivani Babanrao Deshmukh

Sheth Chandanmal Mutha Aryangla Vaidyak Mahavidyalya,Satara

sameershubha85@gmail.com7507043414

Outcome results